JP2009537572A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537572A5
JP2009537572A5 JP2009511321A JP2009511321A JP2009537572A5 JP 2009537572 A5 JP2009537572 A5 JP 2009537572A5 JP 2009511321 A JP2009511321 A JP 2009511321A JP 2009511321 A JP2009511321 A JP 2009511321A JP 2009537572 A5 JP2009537572 A5 JP 2009537572A5
Authority
JP
Japan
Prior art keywords
cyclodextrin
derivatives
hydroxypropyl
auxiliary materials
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009511321A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537572A (ja
JP5525814B2 (ja
Filing date
Publication date
Priority claimed from CN2006100466172A external-priority patent/CN1883492B/zh
Application filed filed Critical
Publication of JP2009537572A publication Critical patent/JP2009537572A/ja
Publication of JP2009537572A5 publication Critical patent/JP2009537572A5/ja
Application granted granted Critical
Publication of JP5525814B2 publication Critical patent/JP5525814B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009511321A 2006-05-22 2007-05-18 20(R)−人参サポニン(ジンセノサイド)Rg3薬用組成物水溶液の調製方法 Expired - Fee Related JP5525814B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2006100466172A CN1883492B (zh) 2006-05-22 2006-05-22 20(R)-人参皂苷Rg3药用组合物水溶液及制备方法
CN200610046617.2 2006-05-22
PCT/CN2007/001635 WO2007134534A1 (fr) 2006-05-22 2007-05-18 Solution aqueuse de composition pharmaceutique de 20(r)-ginsenoside rg3 et procédé correspondant

Publications (3)

Publication Number Publication Date
JP2009537572A JP2009537572A (ja) 2009-10-29
JP2009537572A5 true JP2009537572A5 (https=) 2013-02-14
JP5525814B2 JP5525814B2 (ja) 2014-06-18

Family

ID=37581875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009511321A Expired - Fee Related JP5525814B2 (ja) 2006-05-22 2007-05-18 20(R)−人参サポニン(ジンセノサイド)Rg3薬用組成物水溶液の調製方法

Country Status (10)

Country Link
US (2) US8487090B2 (https=)
EP (1) EP2025339B1 (https=)
JP (1) JP5525814B2 (https=)
KR (2) KR20090014300A (https=)
CN (1) CN1883492B (https=)
AU (1) AU2007252183B2 (https=)
CA (1) CA2653085C (https=)
ES (1) ES2477873T3 (https=)
RU (1) RU2432164C2 (https=)
WO (1) WO2007134534A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011512404A (ja) * 2008-02-19 2011-04-21 ユニジェン インク. 運動能力、疲労回復および抗酸化活性の改善のための、Panax(トチバニンジン属)の種の植物の葉の抽出物または処理されたPanax種植物葉抽出物または双方の混合物を含む組成物
CN101530389B (zh) * 2008-03-11 2012-02-15 沈阳市万嘉生物技术研究所 人参皂苷Rg3磷脂复合物及其制备方法
CN102091114B (zh) * 2009-12-15 2014-11-26 河北以岭医药研究院有限公司 一种中药冻干注射剂及其制备方法
KR100992800B1 (ko) * 2010-05-14 2010-11-08 주식회사 지씨에이치앤피 미량의 진세노사이드 성분이 증가된 신규한 가공인삼 또는 가공인삼추출물의 제조방법
CN103845280B (zh) * 2012-11-30 2017-04-12 富力 一种20(R)‑人参皂苷Rg3外用制剂、制法与用途
CN103845348B (zh) * 2012-11-30 2016-07-13 富力 20(R)-人参皂苷Rg3在制备痛经药物中的应用
KR101316095B1 (ko) * 2013-01-30 2013-10-11 경희대학교 산학협력단 진세노사이드 Rb1 및 Rg3,Compound K,또는 인삼유래 사포닌 추출물을 유효성분으로 함유하는 신경병증성 통증 예방 및 치료용 조성물
KR102021463B1 (ko) * 2013-04-24 2019-09-16 (주)아모레퍼시픽 진세노사이드 Rg3를 함유하는 피부 외용제 조성물
KR101595426B1 (ko) 2013-08-30 2016-02-18 (주)녹십자웰빙 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물
CN104643058A (zh) * 2013-11-21 2015-05-27 富力 20(R)-人参皂苷Rg3在制备改善或/和治疗肝硬化疾病的药物中的应用
CN104644658A (zh) * 2013-11-22 2015-05-27 富力 人参皂苷Rg3在制备用于预防或/和治疗痴呆病症药物中的应用及药物
CN105012315A (zh) * 2014-04-24 2015-11-04 上海中医药大学 20(r)-原人参二醇的医药用途
CN105777838A (zh) * 2014-12-17 2016-07-20 富力 20(R)-人参皂苷Rg3衍生物、制备方法及其应用
CN105982906A (zh) * 2015-02-11 2016-10-05 富力 20(R)-人参皂苷Rg3在制备缓解或/和治疗类风湿病症的药物或保健品中的应用及药物
KR101772759B1 (ko) 2015-09-25 2017-08-30 순천향대학교 산학협력단 안정화된 무정형의 20(R)-진세노사이드 Rg3, 이의 제조방법 및 이를 함유하는 약제학적 제제
CN105878206A (zh) * 2016-03-31 2016-08-24 北京万全德众医药生物技术有限公司 一种人参皂苷Rg3的软胶囊及其制备方法
KR20180000379A (ko) * 2016-06-22 2018-01-03 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 진세노사이드 f1을 유효성분으로 포함하는 면역증강용 조성물
CN108310106A (zh) * 2018-03-30 2018-07-24 吉林省恒实传食品科技发展有限公司 一种补肾填髓、健脑益智、辅助改善记忆的中药组合物及其应用
KR20200112012A (ko) * 2019-03-20 2020-10-05 순천대학교 산학협력단 (R)-진세노사이드 Rg3를 유효성분으로 포함하는 피부상처 치유 또는 피부재생 촉진용 조성물
CN111686104A (zh) * 2020-07-01 2020-09-22 香港浸会大学深圳研究院 小白菊内酯、木犀草素、金圣草素和人参皂苷Rg3的新用途
CN112245443A (zh) * 2020-08-25 2021-01-22 富力 人参皂苷Rg3与Rg5的组合物及其抗肿瘤等药用
CN116077442A (zh) * 2023-01-06 2023-05-09 吉林大学 一种含有人参皂苷Rg3的纳米颗粒及其制备方法和应用
KR102756809B1 (ko) * 2023-10-13 2025-01-22 표재성 난용성 진세노사이드의 수용해도를 높인 조성물, 이를 이용한 화장품조성물 및 건강기능식품

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1186015C (zh) 2001-01-18 2005-01-26 天津实验动物中心 用于冠心病心绞痛的中药复方口腔贴膜
CN1167734C (zh) * 2001-07-02 2004-09-22 董英杰 人参皂甙Rg3羟丙基-β-环糊精包合物及制剂和制备方法
CN1526405A (zh) * 2003-01-06 2004-09-08 山东绿叶天然药物研究开发有限公司 抗肿瘤的人参皂苷Rg3注射剂及其制备方法
CN1569012A (zh) * 2003-07-24 2005-01-26 山东绿叶天然药物研究开发有限公司 20(R)-人参皂苷-Rg3在制备治疗或预防高血压的药物中的应用
CN1569011A (zh) 2003-07-24 2005-01-26 山东绿叶天然药物研究开发有限公司 20(R)-人参皂苷-Rg3在制备治疗或预防心脑血管疾病的药物中的应用
WO2005034963A1 (en) * 2003-10-15 2005-04-21 Panagin Pharmaceuticals Inc. USE OF GINSENOSIDES Rh2 & Rg3, AND AGLYCON GINSENOSIDES FOR THE PREVENTION OF CANCER

Similar Documents

Publication Publication Date Title
JP2009537572A5 (https=)
Kim et al. Solubilization of single-wall carbon nanotubes by supramolecular encapsulation of helical amylose
Malho et al. Facile method for stiff, tough, and strong nanocomposites by direct exfoliation of multilayered graphene into native nanocellulose matrix
Li et al. Functionalization of multiwalled carbon nanotubes and their pH-responsive hydrogels with amyloid fibrils
Guo et al. Supramolecular hydrogels made of end-functionalized low-molecular-weight PEG and α-Cyclodextrin and their hybridization with SiO2 nanoparticles through host− guest interaction
Shvartzman-Cohen et al. Generic approach for dispersing single-walled carbon nanotubes: the strength of a weak interaction
CO6280058A1 (es) Composicion farmaceutica que comprende una sal de estroncio vitamina d y una ciclodextrina
Reid et al. The role of hydrogen bonding in non-ionic polymer adsorption to cellulose nanocrystals and silica colloids
Yan et al. Individually dispersing single-walled carbon nanotubes with novel neutral pH water-soluble chitosan derivatives
Lin et al. Protein-affinity of single-walled carbon nanotubes in water
George et al. Hybrid HPMC nanocomposites containing bacterial cellulose nanocrystals and silver nanoparticles
Sharma et al. Functional nanoparticles obtained from cellulose: Engineering the shape and size of 6-carboxycellulose
Gebauer et al. A transparent hybrid of nanocrystalline cellulose and amorphous calcium carbonate nanoparticles
Liu et al. Noncovalent functionalization of carbon nanotubes with sodium lignosulfonate and subsequent quantum dot decoration
Zheng et al. Fabrication and properties of starch-grafted graphene nanosheet/plasticized-starch composites
Wongmekiat et al. Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of β-cyclodextrin anhydrate and hydrate
Naito et al. Stiffness-and conformation-dependent polymer wrapping onto single-walled carbon nanotubes
Chouit et al. Synthesis and characterization of HDPE/N-MWNT nanocomposite films
Wan et al. Preparation of β-cyclodextrin reinforced waterborne polyurethane nanocomposites with excellent mechanical and self-healing property
Fan et al. Mechanical reinforcement of chitosan using unzipped multiwalled carbon nanotube oxides
Venugopal et al. Nano-dynamic mechanical and thermal responses of single-walled carbon nanotubes reinforced polymer nanocomposite thinfilms
JPWO2020013215A1 (ja) 単離ナノシート及びその製造方法
Zhang et al. Dispersion characterizations and adhesion properties of epoxy composites reinforced by carboxymethyl cellulose surface treated carbon nanotubes
WO2015144983A1 (en) Starch nanoparticles and process for the manufacture thereof
Samra et al. The effects of substituted cyclodextrins on the colloidal and conformational stability of selected proteins